Aim Compare the efficacy of nebulized hypertonic saline and normal saline in the treatment of infants hospitalized for bronchiolitis. Methods This retrospective study was conducted at the Department of Pulmonology, Paediatric Clinic, Clinical Centre University of Sarajevo, covering the period from January 2015 to December 2019 and comprising 380 children aged between 1 and 12 months having bronchiolitis. One group received nebulized hypertonic saline (NHS, 3% NaCl)), and another group received nebulized normal saline (NNS, 0.9% NaCl). The control group did not receive any of these treatment options. Results There was no statistically significant difference between the treatment groups regarding length of hospital stay (LOS) and Clinical Severity Score (CSS) at admission and discharge as well as in oxygen therapy duration and antibiotic use, the duration of symptoms before hospital admission, frequency of nasal discharge, elevated temperature, dyspnoea, cough and dehydration. Conclusion The results of this study are consistent with several recent studies or meta-analyses and support the evidence against the use of NHS in hospitalized infants with mild or moderate bronchiolitis.
Al-Ansari K, Sakran M, Davidson BL, El Sayyed R, Mahjoub H, Ibrahim K. Nebulized 5% or 3% hypertonic or 0.9% saline for treating acute bronchiolitis in infants. J Pediatr 2010;157;(630–4):634 1.
2
Ojha AR, Mathema S, Sah S, Aryal UR. A comparative study on use of 3% saline versus 0.9% saline nebulization in children with bronchiolitis. J Nepal Health Res Counc 2014;12:39–43.
3
Harrison W, Angoulvant F, House S, Gajdos V, Ralston SL. Hypertonic Saline in Bronchiolitis and Type I Error: A Trial Sequential Analysis. Pediatrics 2018:142 20181144.
4
Heikkilä P, Korppi M. Hypertonic saline in bronchiolitis: an updated meta-analysis. Arch Dis Child 2021;106;(102).
5
Brever A, Tomat AM, Seghaye MC. Update on the management of bronchiolitis. Rev Med Liege 2019;74:175–8.
6
Midulla F, Petrarca L, Frassanito A, Mattia G, Zicari AM, Nenna R. Bronchiolitis clinics and medical treatment. Minerva Pediatr 2018;70:600–11.
7
Ouyang Y, Liao H, Hu Y, Luo K, Hu S, Zhu H. Innate Immune Evasion by Human Respiratory Syncytial Virus. Front Microbiol 2022;13;(865592).
8
Köse S, Şehriyaroğlu A, Esen F, Özdemir A, Kardaş Z, Altuğ U, et al. Comparing the efficacy of 7%, 3% and 0.9% saline in moderate to severe bronchiolitis in infants. Balkan Med J 2016;33:193–7.
9
Sauvaget E, David M, Bresson V, Retornaz K, Bosdure E, Dubus JC. Nebulized hypertonic saline and acute viral bronchiolitis in infants: current aspects. Arch Pediatr 2012;19:635–41.
10
Manti S, Staiano A, Orfeo L, Midulla F, Marseglia GL, Ghizzi C, et al. Italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr 2022;49;(19).
11
Jaquet-Pilloud R, Verga ME, Russo M, Gehri M, Pauchard JY. Nebulised hypertonic saline in moderateto-severe bronchiolitis: a randomised clinical trial. Arch Dis Child 2020;105:236–40.
12
Kanjanapradap T, Deerojanawong J, Sritippayawan S, Prapphal N. Does nebulized hypertonic saline shorten hospitalization in young children with acute viral wheezing? Pediatr Pulmonol 2018;53:138–44.
Heikkila P, Renko M, Korppi M. Hypertonic saline inhalations in bronchiolitis-A cumulative metaanalysis. Pediatr Pulmonol 2018;53:233–42.
15
Badgett RG, Vindhyal M, Stirnaman JT, Gibson CM, Halaby R. A living systematic review of nebulized hypertonic saline for acute bronchiolitis in infants. JAMA Pediatr 2015;169:788–9.
16
Korppi M. Therapeutic strategies for pediatric bronchiolitis. Expert Rev Respir Med 2019;13;(95).
17
Yu JF, Zhang Y, Liu ZB, Wang J, Bai LP. 3% nebulized hypertonic saline versus normal saline for infants with acute bronchiolitis: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore 2022;101:e31270.
18
Colosia AD, Masaquel A, Hall CB, Barrett AM, Mahadevia PJ, Yogev R. Residential crowding and severe respiratory syncytial virus disease among infants and young children: a systematic literature review. BMC Infect Dis 2012;12;(95).
19
Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet 2017;389:211–24.
20
Megalaa R, Perez GF, Kilaikode-Cheruveettara S, Kotwal N, Rodriguez-Martinez CE, Nino G. Clinical definition of respiratory viral infections in young children and potential bronchiolitis misclassification. J Investig Med 2018;66:46–51.
21
Korppi M, Koponen P, Nuolivirta K. Upper age limit for bronchiolitis: 12 months or 6 months? Eur RespirJ 2012;39:787–8.
Tan J, Wu J, Jiang W, Huang L, Ji W, Yan Y, et al. Etiology, clinical characteristics and coinfection status of bronchiolitis in Suzhou. BMC Infect Dis 2021;21;(135).
24
Ackermann MR. Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments. ILAR J 2014;55:4–15.
Barbati F, Moriondo M, Pisano L, Calistri E, Lodi L, Ricci S, et al. Epidemiology of respiratory syncytial virus-related hospitalization over a 5-year period in Italy: Evaluation of seasonality and age distribution before vaccine introduction. Vaccines (Basel 2020;8;(15).
27
American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774–93.
28
Hernandez-Cancio S; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014;134:1474–502.
29
Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Pulmonol 2010;45:36–40.
30
Angoulvant F, Bellêttre X, Milcent K, Teglas JP, Claudet I, Le Guen CG, et al. Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis (GUERANDE n.d.
31
M MDG, F S, S L, M C, B N, I C, et al. Effectiveness of nebulized hypertonic saline and epinephrine in hospitalized infants with bronchiolitis. Int J Immunopathol Pharmacol 2012;25:485–91.
32
Florin TA, Byczkowski T, Ruddy RM, Zorc JJ, Test M, Shah SS. Utilization of nebulized 3% saline in infants hospitalized with bronchiolitis. J Pediatr 2015;166:1168–74.
33
Mellick LB, Gonzalez J. The Problematic 2014 American Academy of Pediatrics Bronchiolitis Guidelines. Pediatr Emerg Care 2019;35:654–8.
34
Pandit P, Hoque MA, Pandit H, Dhar SK, Mondal D, Ahmad F. Efficacy of nebulized hypertonic saline (3%) versus normal saline and salbutamol in treating acute bronchiolitis in a tertiary hospital: a randomized controlled trial. Mymensingh Med J 2022;31:295–303.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
